Literature DB >> 7295160

Plaster of paris as an alloplastic implant in the frontal sinus.

W H Beeson.   

Abstract

The use of calcium sulfate (plaster of Paris) has been advocated to repair bony defects because of its unique capability of stimulating osteoneogenesis. Plaster of Paris can be used as a bony alloplast, and it can be analyzed histologically. Sinus roentgenograms and technetium Tc 99m medronate bone scanning further support the use of plaster of Paris as an alloplast and assess its osteoneogenic capacity when implanted in the frontal sinus of dogs; complete bone regeneration was demonstrated in six dogs within four to six months. The use of plaster of Paris for bone reconstruction in the head and neck can be applied in surgery. The experience with plaster of Paris to date, although limited, shows it to be safe and highly encouraging as an effective bone allograft.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295160     DOI: 10.1001/archotol.1981.00790470012004

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  4 in total

1.  The use of particulate hydroxyapatite and plaster of Paris in aesthetic and reconstructive surgery.

Authors:  N G Georgiade; J Hanker; S Levin; G Ruff
Journal:  Aesthetic Plast Surg       Date:  1993       Impact factor: 2.326

2.  Bone replacement by ionomer cement in osteoplastic frontal sinus operations.

Authors:  A Weber; A May; C von Ilberg
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  Light and transmission electron microscopic studies following frontal sinus obliteration with ionomer cement in cats.

Authors:  S Dazert; W H Muss
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

4.  Evaluation of surgical cavities filled with three types of calcium sulfate.

Authors:  Sergio Toshinori Maeda; Clovis Monteiro Bramane; Rumio Taga; Roberto Brandão Garcia; Ivaldo Gomes de Moraes; Norberti Bernadineli
Journal:  J Appl Oral Sci       Date:  2007-10       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.